Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$55.2K
10 trades · 5 insiders
Net · 90d
$-55.2K
Insiders on file
14
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Ambrose Allison | General Counsel | 8 | $0 | $12.6K | 2026-09-16 |
| Deykin Aaron | Chief Medical Officer | 7 | $0 | $23.6K | 2026-09-16 |
| Houghton Adam | Chief Business Officer | 7 | $0 | $18.4K | 2026-09-16 |
| Sutherland Everett Rand | Chief Executive Officer, Director | 7 | $0 | $55.2K | 2026-09-16 |
| GRAY MICHAEL | CFO and COO | 7 | $0 | $22.5K | 2026-09-16 |
| Ruddy Marcella K. | Director | 3 | $0 | $0 | 2026-06-09 |
| Fleming Harold Edward | Director | 3 | $0 | $0 | 2026-06-09 |
| Chimovits Erez | Director, 10% Owner | 11 | $14.03M | $0 | 2026-06-09 |
| Ratcliffe Liam | Director | 3 | $0 | $0 | 2026-06-09 |
| Beckman Daniella | Director | 3 | $0 | $0 | 2026-06-09 |
| Renaud Ronald C JR | Director | 3 | $0 | $0 | 2026-06-09 |
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% Owner | 2 | $0 | $0 | 2024-10-15 |
| Access Industries Holdings LLC | 10% Owner | 5 | $19.98M | $0 | 2024-10-15 |
| ORBIMED ADVISORS LLC | Director, 10% Owner | 8 | $14.03M | $0 | 2024-10-15 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Ambrose Allison | General Counsel | S Sale | 2026-09-16 | 2026-09-17 | 485 | $5.49 | $2.7K | 15,563 | SEC↗ |
| GRAY MICHAEL | CFO and COO | S Sale | 2026-09-16 | 2026-09-17 | 853 | $5.49 | $4.7K | 27,942 | SEC↗ |
| Houghton Adam | Chief Business Officer | S Sale | 2026-09-16 | 2026-09-17 | 700 | $5.49 | $3.8K | 22,901 | SEC↗ |
| Sutherland Everett Rand | Chief Executive Officer | S Sale | 2026-09-16 | 2026-09-17 | 2,095 | $5.49 | $11.5K | 68,717 | SEC↗ |
| Deykin Aaron | Chief Medical Officer | S Sale | 2026-09-16 | 2026-09-17 | 895 | $5.49 | $4.9K | 32,302 | SEC↗ |
| Sutherland Everett Rand | Chief Executive Officer, Dir | S Sale | 2026-09-16 | 2026-09-17 | 2,095 | $5.49 | $11.5K | 68,717 | SEC↗ |
| Houghton Adam | Chief Business Officer | S Sale | 2026-09-16 | 2026-09-17 | 700 | $5.49 | $3.8K | 22,901 | SEC↗ |
| GRAY MICHAEL | CFO and COO | S Sale | 2026-09-16 | 2026-09-17 | 853 | $5.49 | $4.7K | 27,942 | SEC↗ |
| Deykin Aaron | Chief Medical Officer | S Sale | 2026-09-16 | 2026-09-17 | 895 | $5.49 | $4.9K | 32,302 | SEC↗ |
| Ambrose Allison | General Counsel | S Sale | 2026-09-16 | 2026-09-17 | 485 | $5.49 | $2.7K | 15,563 | SEC↗ |
| Ambrose Allison | General Counsel | S Sale | 2026-06-16 | 2026-06-17 | 477 | $6.10 | $2.9K | 16,048 | SEC↗ |
| Deykin Aaron | Chief Medical Officer | S Sale | 2026-06-16 | 2026-06-17 | 895 | $6.10 | $5.5K | 33,197 | SEC↗ |
| Houghton Adam | Chief Business Officer | S Sale | 2026-06-16 | 2026-06-17 | 700 | $6.10 | $4.3K | 23,601 | SEC↗ |
| Sutherland Everett Rand | Chief Executive Officer | S Sale | 2026-06-16 | 2026-06-17 | 2,095 | $6.10 | $12.8K | 70,812 | SEC↗ |
| GRAY MICHAEL | CFO and COO | S Sale | 2026-06-16 | 2026-06-17 | 853 | $6.10 | $5.2K | 28,795 | SEC↗ |
| Chimovits Erez | Director | A Award deriv | 2026-06-09 | 2026-06-11 | 17,096 | — | $0 | 17,096 | SEC↗ |
| Ratcliffe Liam | Director | A Award deriv | 2026-06-09 | 2026-06-11 | 17,096 | — | $0 | 17,096 | SEC↗ |
| Beckman Daniella | Director | A Award deriv | 2026-06-09 | 2026-06-11 | 17,096 | — | $0 | 17,096 | SEC↗ |
| Fleming Harold Edward | Director | A Award deriv | 2026-06-09 | 2026-06-11 | 17,096 | — | $0 | 17,096 | SEC↗ |
| Renaud Ronald C JR | Director | A Award deriv | 2026-06-09 | 2026-06-11 | 17,096 | — | $0 | 17,096 | SEC↗ |
| Ruddy Marcella K. | Director | A Award deriv | 2026-06-09 | 2026-06-11 | 17,096 | — | $0 | 17,096 | SEC↗ |
| Houghton Adam | Chief Business Officer | S Sale | 2026-03-16 | 2026-03-17 | 699 | $9.29 | $6.5K | 24,301 | SEC↗ |
| Ambrose Allison | General Counsel | S Sale | 2026-03-16 | 2026-03-17 | 475 | $9.29 | $4.4K | 16,525 | SEC↗ |
| Sutherland Everett Rand | Chief Executive Officer | S Sale | 2026-03-16 | 2026-03-17 | 2,093 | $9.29 | $19.4K | 72,907 | SEC↗ |
| Deykin Aaron | Chief Medical Officer | S Sale | 2026-03-16 | 2026-03-17 | 894 | $9.29 | $8.3K | 32,687 | SEC↗ |
| GRAY MICHAEL | CFO and COO | S Sale | 2026-03-16 | 2026-03-17 | 852 | $9.29 | $7.9K | 29,648 | SEC↗ |
| Sutherland Everett Rand | Chief Executive Officer | A Award deriv | 2026-01-02 | 2026-01-06 | 225,000 | — | $0 | 225,000 | SEC↗ |
| Houghton Adam | Chief Business Officer | A Award deriv | 2026-01-02 | 2026-01-06 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Ambrose Allison | General Counsel | A Award deriv | 2026-01-02 | 2026-01-06 | 51,000 | — | $0 | 51,000 | SEC↗ |
| Deykin Aaron | Chief Medical Officer | A Award deriv | 2026-01-02 | 2026-01-06 | 96,000 | — | $0 | 96,000 | SEC↗ |
| GRAY MICHAEL | CFO and COO | A Award deriv | 2026-01-02 | 2026-01-06 | 91,500 | — | $0 | 91,500 | SEC↗ |
| Sutherland Everett Rand | Chief Executive Officer | A Award | 2026-01-02 | 2026-01-06 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Houghton Adam | Chief Business Officer | A Award | 2026-01-02 | 2026-01-06 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Ambrose Allison | General Counsel | A Award | 2026-01-02 | 2026-01-06 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Deykin Aaron | Chief Medical Officer | A Award | 2026-01-02 | 2026-01-06 | 32,000 | — | $0 | 33,581 | SEC↗ |
| GRAY MICHAEL | CFO and COO | A Award | 2026-01-02 | 2026-01-06 | 30,500 | — | $0 | 30,500 | SEC↗ |
| Ratcliffe Liam | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 17,096 | — | $0 | 17,096 | SEC↗ |
| Fleming Harold Edward | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 17,096 | — | $0 | 17,096 | SEC↗ |
| Chimovits Erez | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 17,096 | — | $0 | 17,096 | SEC↗ |
| Renaud Ronald C JR | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 17,096 | — | $0 | 17,096 | SEC↗ |
| Beckman Daniella | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 17,096 | — | $0 | 17,096 | SEC↗ |
| Ruddy Marcella K. | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 17,096 | — | $0 | 17,096 | SEC↗ |
| Ambrose Allison | General Counsel | A Award deriv | 2025-02-06 | 2025-02-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Deykin Aaron | Chief Medical Officer | A Award deriv | 2025-02-06 | 2025-02-07 | 165,000 | — | $0 | 165,000 | SEC↗ |
| Houghton Adam | Chief Business Officer | A Award deriv | 2025-02-06 | 2025-02-07 | 140,000 | — | $0 | 140,000 | SEC↗ |
| GRAY MICHAEL | CFO and COO | A Award deriv | 2025-02-06 | 2025-02-07 | 195,000 | — | $0 | 195,000 | SEC↗ |
| Sutherland Everett Rand | Chief Executive Officer | A Award deriv | 2025-02-06 | 2025-02-07 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Ambrose Allison | General Counsel | A Award deriv | 2024-12-16 | 2024-12-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Wellington Biomedical Innovati | 10% Owner | C Conversion deriv | 2024-10-15 | 2024-10-15 | 852,940 | — | $0 | 0 | SEC↗ |
| Access Industries Holdings LLC | 10% Owner | C Conversion deriv | 2024-10-15 | 2024-10-17 | 1,172,410 | — | $0 | 0 | SEC↗ |
| Access Industries Holdings LLC | 10% Owner | C Conversion deriv | 2024-10-15 | 2024-10-17 | 3,147,000 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2024-10-15 | 2024-10-17 | 524,500 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2024-10-15 | 2024-10-17 | 2,098,000 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2024-10-15 | 2024-10-17 | 197,456 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2024-10-15 | 2024-10-17 | 789,833 | — | $0 | 0 | SEC↗ |
| Chimovits Erez | Director, 10% Owner | C Conversion deriv | 2024-10-15 | 2024-10-17 | 789,833 | — | $0 | 0 | SEC↗ |
| Chimovits Erez | Director, 10% Owner | C Conversion deriv | 2024-10-15 | 2024-10-17 | 524,500 | — | $0 | 0 | SEC↗ |
| Chimovits Erez | Director, 10% Owner | C Conversion deriv | 2024-10-15 | 2024-10-17 | 2,098,000 | — | $0 | 0 | SEC↗ |
| Chimovits Erez | Director, 10% Owner | C Conversion deriv | 2024-10-15 | 2024-10-17 | 197,456 | — | $0 | 0 | SEC↗ |
| Wellington Biomedical Innovati | 10% Owner | C Conversion | 2024-10-15 | 2024-10-15 | 894,733 | — | $0 | 894,733 | SEC↗ |
| Access Industries Holdings LLC | 10% Owner | C Conversion | 2024-10-15 | 2024-10-17 | 1,172,410 | — | $0 | 5,494,410 | SEC↗ |
| Access Industries Holdings LLC | 10% Owner | C Conversion | 2024-10-15 | 2024-10-17 | 3,147,000 | — | $0 | 4,322,000 | SEC↗ |
| Access Industries Holdings LLC | 10% Owner | P Buy | 2024-10-15 | 2024-10-17 | 1,175,000 | $17.00 | $19.98M | 1,175,000 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | P Buy | 2024-10-15 | 2024-10-17 | 660,000 | $17.00 | $11.22M | 4,554,873 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion | 2024-10-15 | 2024-10-17 | 721,956 | — | $0 | 973,716 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | P Buy | 2024-10-15 | 2024-10-17 | 165,000 | $17.00 | $2.81M | 1,138,716 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion | 2024-10-15 | 2024-10-17 | 2,887,833 | — | $0 | 3,894,873 | SEC↗ |
| Chimovits Erez | Director, 10% Owner | P Buy | 2024-10-15 | 2024-10-17 | 660,000 | $17.00 | $11.22M | 4,554,873 | SEC↗ |
| Chimovits Erez | Director, 10% Owner | C Conversion | 2024-10-15 | 2024-10-17 | 2,887,833 | — | $0 | 3,894,873 | SEC↗ |
| Chimovits Erez | Director, 10% Owner | P Buy | 2024-10-15 | 2024-10-17 | 165,000 | $17.00 | $2.81M | 1,138,716 | SEC↗ |
| Chimovits Erez | Director, 10% Owner | C Conversion | 2024-10-15 | 2024-10-17 | 721,956 | — | $0 | 973,716 | SEC↗ |
| Ratcliffe Liam | Director | A Award deriv | 2024-10-10 | 2024-10-15 | 17,096 | — | $0 | 17,096 | SEC↗ |
| Fleming Harold Edward | Director | A Award deriv | 2024-10-10 | 2024-10-15 | 17,096 | — | $0 | 17,096 | SEC↗ |
| Ruddy Marcella K. | Director | A Award deriv | 2024-10-10 | 2024-10-15 | 17,096 | — | $0 | 17,096 | SEC↗ |
| Chimovits Erez | Director | A Award deriv | 2024-10-10 | 2024-10-15 | 17,096 | — | $0 | 17,096 | SEC↗ |
| Beckman Daniella | Director | A Award deriv | 2024-10-10 | 2024-10-15 | 34,681 | — | $0 | 34,681 | SEC↗ |
| Renaud Ronald C JR | Director | A Award deriv | 2024-10-10 | 2024-10-15 | 17,096 | — | $0 | 17,096 | SEC↗ |